Over a dozen companies, including Hetero, Sun Pharma, Natco and Dr Reddy’s are in the process of rolling out the oral therapy developed by Merck and and its partner, Ridgeback Biotherapeutics, at prices ranging between Rs 1,500 and Rs 2,500 for the complete treatment, sources told TOI.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3qHDw9y
कोई टिप्पणी नहीं:
एक टिप्पणी भेजें